Immunifyme Healthcare Technologies Private Limited, a active private limited company, was established on 10 July 2019 in Gurgaon, Haryana, India. Engaging in hospitals within the healthcare sector, it holds CIN: U85100HR2019PTC081395. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹24.17 Cr and a paid-up capital of ₹24.05 Cr.
It upholds a compliant status. Employing 2 professional, Its leadership includes Nadeera Nilupamali Sirisena Pahala Dickwellage (Director), Sudheera Lakmal Pahala Dickwellage (Director), Neeraj Kumar Mehta (Director). Past directors included Hira Kumar. Its latest AGM occurred on 21 September 2024, with the balance sheet filed on 31 March 2024. It is based at 149, National Media Center Shankar Chowk, Gurgaon, Haryana, 122002.
U85100HR2019PTC081395
081395
10 July 2019
₹24.17 Cr
₹24.05 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Immunifyme Healthcare Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nadeera Nilupamali Sirisena Pahala Dickwellage | Director | 10 Jul 2019 | Current |
| Sudheera Lakmal Pahala Dickwellage | Director | 10 Jul 2019 | Current |
| Neeraj Kumar Mehta | Director | 10 Jul 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Immunifyme Healthcare Technologies Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2020, Immunifyme Healthcare Technologies had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Immunifyme Healthcare Technologies has a workforce of 2 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Immunifyme Healthcare Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Immunifyme Healthcare Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Immunifyme Healthcare Technologies Private Limited last Annual general meeting of members was held on 21 Sep 2024 as per latest MCA records. was recorded as a recent event.
Immunifyme Healthcare Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Poonam Rani was appointed as a Company Secretary was appointed as a Company Secretary on 15 Jan 2024 & has been associated with this company since 1 year 11 months . was completed.
Progress on Nadeera Nilupamali Sirisena Pahala Dickwellage was appointed as a Director was appointed as a Director on 10 Jul 2019 & has been associated with this company since 6 years 5 months . was documented.
The activity Sudheera Lakmal Pahala Dickwellage was appointed as a Director was appointed as a Director on 10 Jul 2019 & has been associated with this company since 6 years 5 months . was completed.
Neeraj Kumar Mehta was appointed as a Director was appointed as a Director on 10 Jul 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.
The CIN of Immunifyme Healthcare Technologies Private Limited is U85100HR2019PTC081395.
Immunifyme Healthcare Technologies Private Limited is headquartered at 149, National Media Center Shankar Chowk, Gurgaon, Haryana, 122002.
Immunifyme Healthcare Technologies Private Limited was incorporated on 10 July 2019.
The current directors of Immunifyme Healthcare Technologies Private Limited are
The primary industry of Immunifyme Healthcare Technologies Private Limited is Healthcare.
Immunifyme Healthcare Technologies Private Limited is unlisted.
The authorized capital of Immunifyme Healthcare Technologies Private Limited is ₹24.17 Cr, and the paid-up capital is ₹24.05 Cr.
The compliance status of Immunifyme Healthcare Technologies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX